Synopsys Inc (SNPS)vsVivoPower PLC (VIVO)
SNPS
Synopsys Inc
$489.02
+1.73%
TECHNOLOGY · Cap: $95.30B
VIVO
VivoPower PLC
$2.91
-8.78%
TECHNOLOGY · Cap: $53.56M
Smart Verdict
WallStSmart Research — data-driven comparison
Synopsys Inc generates 13127213% more annual revenue ($8.01B vs $61,000). SNPS leads profitability with a 13.8% profit margin vs 0.0%. SNPS earns a higher WallStSmart Score of 47/100 (D+).
SNPS
Hold47
out of 100
Grade: D+
VIVO
Avoid26
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 65.5% year-over-year
Large-cap with strong market position
Revenue surging 47.6% year-over-year
Reasonable price relative to book value
Areas to Watch
ROE of 5.5% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : SNPS
The strongest argument for SNPS centers on Revenue Growth, Market Cap. Revenue growth of 65.5% demonstrates continued momentum.
Bull Case : VIVO
The strongest argument for VIVO centers on Revenue Growth, Price/Book. Revenue growth of 47.6% demonstrates continued momentum.
Bear Case : SNPS
The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 75.2x leaves little room for execution misses.
Bear Case : VIVO
The primary concerns for VIVO are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
SNPS profiles as a growth stock while VIVO is a hypergrowth play — different risk/reward profiles.
SNPS carries more volatility with a beta of 1.25 — expect wider price swings.
SNPS is growing revenue faster at 65.5% — sustainability is the question.
SNPS generates stronger free cash flow (822M), providing more financial flexibility.
Bottom Line
SNPS scores higher overall (47/100 vs 26/100) and 65.5% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Synopsys Inc
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.
Visit Website →VivoPower PLC
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?